Individualizing T2DM Treatment: Determining Optimal Pathways that Lead to Achieving Target Goals

CME Program from The Doctor's Channel

Individualizing T2DM Treatment: Determining Optimal Pathways that Lead to Achieving Target Goals will review how to examine the differences in mechanism of action, efficacy, and safety of treatment options that target the incretin pathway. The on-demand interviews also talk about how to incorporate evidence-based guidelines and recommendations into practice when considering the use of incretin-based therapies for type 2 diabetes.

Already a member? Click here to sign in

Step 1: Not registered? Please complete this form to view content

First Name *Last Name *Organization Name *Address *City *StatePostal Code *Country *Phone *

Step 2: Create Your Medical Product Guide Account

Email *Password *

Step 3: Create Your Professional Information

Profession *

By clicking the button above you agree to our Terms of Use. We take your privacy seriously. For more information please read our Privacy Policy. By registering with the Enterprise Guide you will automatically receive our weekly Product Update and Technology Insider eNewsletters.